Datasets:
jarrydmartinx
/
support2

Dataset card Data Studio Files
xet
Community
age
float64
18
102
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
⌀
income
stringclasses
4 values
scoma
float64
0
100
⌀
charges
float64
1.17k
1.44M
⌀
totcst
float64
0
633k
⌀
totmcst
float64
-102.72
711k
⌀
avtisst
float64
1
83
⌀
race
stringclasses
5 values
sps
float64
0.2
99.2
⌀
aps
float64
0
143
⌀
surv2m
float64
0
0.97
⌀
surv6m
float64
0
0.95
⌀
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
⌀
prg6m
float64
0
1
⌀
dnr
stringclasses
3 values
dnrday
float64
-88
285
⌀
meanbp
float64
0
195
⌀
wblc
float64
0
200
⌀
hrt
float64
0
300
⌀
resp
float64
0
90
⌀
temp
float64
31.7
41.7
⌀
pafi
float64
12
890
⌀
alb
float64
0.4
29
⌀
bili
float64
0.1
63
⌀
crea
float64
0.1
21.5
⌀
sod
float64
110
181
⌀
ph
float64
6.83
7.77
⌀
glucose
float64
0
1.09k
⌀
bun
float64
1
300
⌀
urine
float64
0
9k
⌀
adlp
float64
0
7
⌀
adls
float64
0
7
⌀
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
event_times
int64
3
2.03k
event_indicators
int64
0
1
74.836
female
0
55
Coma
Coma
2
12
$11-$25k
44
121,446
73,198.25
74,076
22.75
white
27.898438
42
0.231995
0.166992
3
0
0
no
0.5
0.4
no dnr
55
78
13.798828
105
16
36
145
null
null
0.899902
135
7.449219
96
31
3,745
null
0
adl>=4 (>=5 if sur)
0
205
1
67.29895
male
0
16
Lung Cancer
Cancer
1
12
under $11k
0
16,352
11,122.2734
12,129
9
white
21.597656
14
0.5979
0.279968
1
0
0
metastatic
0.6
0.2
dnr after sadm
13
67
9.898438
105
16
36.09375
null
null
0.899902
0.899902
135
null
87
12
1,650
0
0
no(M2 and SIP pres)
0
145
1
65.03796
female
0
40
ARF/MOSF w/Sepsis
ARF/MOSF
0
11
>$50k
0
102,799
63,792.2188
61,464
26.25
white
26.199219
44
0.772949
0.699951
1
0
0
no
0.5
0.5
no dnr
40
105
2.599609
130
8
38.19531
260
1.199951
null
1.199951
136
7.399414
104
15
1,373
null
6
no(M2 and SIP pres)
6
772
0
55.05499
male
1
6
MOSF w/Malig
ARF/MOSF
1
24
>$50k
0
44,118
26,434.5938
25,920
31
white
40
73
0.107986
0.045998
18
0
0
metastatic
0.1
0
dnr after sadm
2
72
10.398438
101
16
36.5
null
3.799805
0.899902
1.199951
133
null
265
18
1,775
null
null
<2 mo. follow-up
2.449219
6
1
28.19399
female
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
11
null
0
96,558
57,177.4688
61,408
38
white
46.296875
74
0.416992
0.297974
13
0
0
no
0.1
0.05
dnr after sadm
2
62
6.399414
60
10
36.09375
170
null
null
0.599976
139
7.419922
115
10
3,025
null
1
<2 mo. follow-up
1
11
1
60.66299
male
1
33
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
9
188,767
103,457.812
109,782
35.75
white
50.398438
58
0.112991
0.048996
3
0
0
no
0.8
0.7
dnr after sadm
33
52
21
145
10
39.29688
182.21875
1.899902
2.899902
1.5
139
7.5
196
55
330
null
null
<2 mo. follow-up
1.978027
33
1
55.56198
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
35,993
20,256.8438
21,664
22.666656
white
26.5
31
0.802979
0.737915
1
0
0
no
0.8
0.7
no dnr
16
73
8.898438
115
24
35.59375
623.75
2
6.199219
1
128
7.469727
91
6
750
null
2
SIP>=30
2
770
0
75.28796
female
1
5
Coma
Coma
2
14
under $11k
61
null
11,422.7578
14,040
34
white
41.59375
72
0.006
0.002
1
0
0
no
0.15
0.1
dnr after sadm
2
98
5
70
20
36.29688
null
2.899902
0.399963
1.099854
141
null
158
5
9,000
null
1
<2 mo. follow-up
1
5
1
75.27698
female
0
53
COPD
COPD/CHF/Cirrhosis
3
null
>$50k
37
129,050
77,979.6875
77,337
26.25
white
20.597656
29
0.689941
0.523926
1
0
0
no
0.5
0.5
no dnr
53
75
23.398438
115
35
38.5
211.40625
2.199707
0.799927
1.099854
138
7.429688
174
13
1,860
null
0
no(M2 and SIP pres)
0
769
0
53.02698
male
0
5
CHF
COPD/CHF/Cirrhosis
5
8
under $11k
0
3,519
2,716.1777
2,575
2
black
14.199219
24
0.930908
0.882935
1
1
0
no
null
null
no dnr
5
83
7.799805
55
12
35.39844
512
2
3.799805
3.299805
134
7.40918
141
97
1,900
0
null
no(M2 and SIP pres)
0.494751
385
1
65.44299
male
0
14
Lung Cancer
Cancer
2
19
null
0
15,948
10,670.1875
12,667
7.333332
white
18.898438
21
0.666992
0.366943
1
0
0
metastatic
0.7
0.3
no dnr
14
108
15.298828
125
38
37.59375
252
null
0.799927
0.699951
136
7.349609
136
9
665
null
5
null
5
105
1
54.543
male
0
10
Lung Cancer
Cancer
1
5
$25-$50k
0
17,099
10,467.5703
10,611
11
white
4.699219
2
0.891968
0.75293
1
0
0
metastatic
1
0.5
no dnr
10
112
25.796875
100
12
36.39844
348
1.599854
0.399963
0.5
138
7.429688
144
10
990
0
0
no(M2 and SIP pres)
0
192
1
80.28198
male
1
5
Lung Cancer
Cancer
2
null
null
26
9,725
null
null
20
black
30.199219
43
0.182983
0.014999
1
0
0
metastatic
null
null
dnr after sadm
3
93
8
65
20
36.19531
null
null
0.5
0.899902
138
null
199
15
2,400
null
6
<2 mo. follow-up
6
5
1
52.88199
female
0
11
Cirrhosis
COPD/CHF/Cirrhosis
1
17
null
0
30,125
19,121
19,548
12.5
white
22
34
0.748901
0.60498
8
0
0
no
null
null
no dnr
11
48
15.298828
105
60
37.89844
295
null
0.699951
1.5
134
7.379883
203
27
2,200
1
1
null
1
504
1
60.65399
male
0
21
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
null
0
71,922
39,465
42,149
29
white
29.199219
44
0.721924
0.636963
2
0
0
no
0.55
0.5
no dnr
21
42
1.299805
75
12
35.69531
230
2.5
22.296875
2.199707
146
7.339844
157
84
340
0
0
no(M2 and SIP pres)
0
67
1
55.181
male
0
7
Lung Cancer
Cancer
1
12
$25-$50k
0
4,957
3,451.5
3,383
3.5
white
13.798828
9
0.785889
0.549927
1
0
0
metastatic
0.6
0.25
no dnr
7
118
14
125
10
36.69531
260.6875
4.099609
null
0.699951
140
7.369141
119
11
2,670
2
0
SIP>=30
0
288
1
50.01199
male
0
3
Lung Cancer
Cancer
1
20
>$50k
0
6,388
3,168.7422
1,350
11
white
12
6
0.81897
0.609985
1
0
0
metastatic
1
0.8
no dnr
3
65
9.298828
120
10
36.29688
177.75
1.5
4.199219
3.199707
146
7.389648
214
85
2,815
null
null
no(M2 and SIP pres)
1.865723
764
0
22.62799
male
0
37
ARF/MOSF w/Sepsis
ARF/MOSF
0
15
$25-$50k
0
323,059
189,009.25
197,291
40
black
29.097656
51
0.826904
0.767944
10
0
0
no
null
null
no dnr
37
72
6.099609
60
20
36.5
null
null
null
2.099609
139
null
83
53
1,300
null
4
no(M2 and SIP pres)
4
763
0
47.62799
male
0
76
MOSF w/Malig
ARF/MOSF
1
12
null
0
376,664
207,720
198,047
45.25
white
30.699219
56
0.399963
0.280945
7
0
0
metastatic
null
null
no dnr
76
70
23.296875
64
28
37.79688
null
2.5
11.898438
0.599976
131
null
33
4
null
null
0
adl>=4 (>=5 if sur)
0
521
1
73.59094
female
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
under $11k
0
73,327
43,064.3438
48,526
27.25
white
22.097656
28
0.804932
0.740967
1
1
0
no
0.6
0.4
no dnr
25
127
0.399963
115
33
36.69531
428.5625
2.899902
22.398438
8.599609
154
7.30957
195
142
2,130
null
0
no(M2 and SIP pres)
0
762
0
36.76099
female
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
under $11k
0
41,480
24,610.7969
23,436
29.333328
black
26.097656
33
0.863892
0.815918
1
0
0
no
0.7
0.7
no dnr
14
72
14.599609
110
32
38.09375
200
2.099609
0.699951
0.699951
143
7.449219
206
10
3,200
null
0
no(M2 and SIP pres)
0
761
0
82.75696
male
0
29
ARF/MOSF w/Sepsis
ARF/MOSF
2
6
$11-$25k
0
73,813
44,928.0625
47,449
20.5
white
17.199219
17
0.797974
0.731934
8
0
1
no
0.8
0.8
no dnr
29
72
6.5
45
16
36
null
null
null
1.799805
138
null
188
57
2,550
null
null
no(M2 and SIP pres)
4.93457
279
1
70.21997
female
0
10
Colon Cancer
Cancer
1
12
null
0
16,592
9,469.4141
6,130
9.5
white
14.898438
5
0.833984
0.638916
1
0
0
metastatic
0.8
0.6
no dnr
10
55
15.199219
145
0
36.69531
190
null
null
2.299805
136
7.489258
361
48
2,670
1
0
no(M2 and SIP pres)
0
761
0
77.35498
male
0
28
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
null
0
63,807
38,045.8125
41,215
24.25
white
28.796875
49
0.668945
0.572998
1
0
0
no
null
null
dnr after sadm
11
128
14.898438
110
35
36
98.75
null
1.599854
0.699951
136
7.519531
267
26
1,535
null
2
null
2
66
1
48.40198
male
0
5
Lung Cancer
Cancer
1
16
$25-$50k
0
4,142
2,687.8477
2,925
7
white
25.296875
26
0.56189
0.23999
1
0
0
metastatic
0.1
0
no dnr
5
135
30.898438
125
18
38
208.5625
null
7.299805
1.199951
141
7.439453
109
35
1,350
0
1
<2 mo. follow-up
1
21
1
38.875
female
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$25-$50k
0
113,529
65,544.0625
62,624
16
white
21.199219
16
0.859985
0.81189
42
0
0
no
0.8
0.8
no dnr
19
53
13
55
22
38.79688
191.40625
2.099609
1.599854
7.5
121
7.379883
150
113
88
5
7
adl>=4 (>=5 if sur)
7
760
0
65.93597
female
1
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
15
under $11k
0
62,017
36,789.2188
37,194
36
black
33.195313
80
0.631958
0.529907
1
1
0
no
0.75
0.65
dnr after sadm
9
60
16.398438
125
10
38.19531
133.3125
2.399902
2.399902
1.099854
130
7.489258
97
9
1,970
null
0
<2 mo. follow-up
0
14
1
60.44397
female
0
16
Coma
Coma
0
12
under $11k
44
44,441
27,747.375
32,373
25
white
20.699219
22
0.581909
0.515991
3
0
0
no
0.6
0.6
dnr after sadm
1
67
19.5
108
20
34.29688
338.0625
null
3.699707
3.299805
147
7.539062
111
78
1,300
null
0
adl>=4 (>=5 if sur)
0
759
0
57.51099
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
16
$25-$50k
0
76,162
43,470.0625
48,418
27.666656
white
26.199219
36
0.775879
0.703979
3
1
0
no
0.85
0.8
no dnr
18
58
11.798828
155
40
37.89844
130
2.5
6.899414
1.199951
134
7.609375
167
48
2,002
null
0
no(M2 and SIP pres)
0
759
0
58.28098
female
0
9
COPD
COPD/CHF/Cirrhosis
3
13
null
0
10,409
6,518.168
7,685
10
white
13.798828
14
0.932983
0.885986
1
0
0
no
0.9
0.9
no dnr
9
118
11
55
22
37.79688
272.5
null
null
0.699951
136
7.429688
153
5
5,295
1
2
no(M2 and SIP pres)
2
759
0
62.80899
female
1
15
MOSF w/Malig
ARF/MOSF
1
12
$25-$50k
26
78,898
44,584.9688
44,423
51.666657
white
26.898438
43
0.521973
0.405945
1
0
0
yes
0.5
0.2
dnr after sadm
9
112
17.597656
135
44
38.59375
146.65625
2.599609
0.5
1.699951
149
7.429688
148
23
1,530
null
6
<2 mo. follow-up
6
15
1
51.16498
male
0
5
Lung Cancer
Cancer
1
15
>$50k
0
6,343
3,586.1406
2,249
10
white
21.398438
9
0.649902
0.343994
1
0
0
metastatic
0.9
0.5
no dnr
5
130
14.5
75
25
38.09375
300
null
0.5
1.5
146
7.449219
384
39
3,890
0
0
no(M2 and SIP pres)
0
76
1
60.52798
female
0
11
COPD
COPD/CHF/Cirrhosis
1
9
$11-$25k
0
10,831
7,174.082
7,566
10.5
white
19.796875
20
0.883911
0.806885
1
0
0
no
0.9
0.9
no dnr
11
68
14.5
125
12
35.59375
220
null
1.799805
1.5
140
7.429688
177
41
4,000
0
0
no(M2 and SIP pres)
0
757
0
45.56299
male
0
13
MOSF w/Malig
ARF/MOSF
1
18
under $11k
0
92,440
48,631.625
37,753
40
white
49.59375
88
0.014
0.003
8
0
0
metastatic
0.5
0.5
no dnr
13
50
18.296875
115
20
36.5
72
2.099609
6.299805
5.699219
139
7.339844
100
63
580
null
null
no(M2 and SIP pres)
2.366211
756
0
71.16998
female
0
53
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
under $11k
0
248,546
142,914.625
144,234
43.75
black
21.199219
32
0.771973
0.697998
12
1
0
no
null
null
no dnr
53
123
16.796875
75
16
36.89844
130
2.399902
null
1.299805
137
7.349609
128
26
2,240
null
1
SIP>=30
1
756
0
76.85999
female
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
0
14
$11-$25k
0
35,513
22,049.8125
23,664
15.333328
white
28
36
0.687988
0.595947
1
0
0
no
0.7
0.5
no dnr
18
125
14.298828
135
12
39
263.3125
3.399902
1.899902
0.699951
138
7.529297
120
11
2,985
3
3
no(M2 and SIP pres)
3
756
0
66.612
male
0
9
MOSF w/Malig
ARF/MOSF
2
17
$25-$50k
0
15,178
9,082.9531
9,389
15
other
34.796875
71
0.329956
0.214996
1
1
0
metastatic
null
null
no dnr
9
38
15.599609
75
20
36.79688
131.40625
2.099609
3.899902
4.699219
144
7.419922
89
49
120
0
2
adl>=4 (>=5 if sur)
2
333
1
80.23798
female
0
27
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
null
0
42,852
26,986.3438
25,946
10.75
black
29
24
0.589966
0.480957
5
0
0
no
null
null
no dnr
27
50
5.399414
195
30
39.19531
270
3.199707
0.899902
4.899414
136
7.459961
149
47
460
null
5
adl>=4 (>=5 if sur)
5
754
0
30.245
male
1
4
Coma
Coma
1
null
null
100
11,320
6,489.4727
6,158
30
black
81.6875
83
0
0
1
0
0
metastatic
null
null
no dnr
4
47
17.296875
125
38
36.69531
116.65625
null
null
1.099854
142
7.299805
273
58
5,450
null
null
<2 mo. follow-up
1.56958
4
1
50.36798
female
1
24
Coma
Coma
1
18
$11-$25k
0
56,208
34,438.6875
34,426
23
black
35.59375
83
0.357971
0.284973
1
0
0
metastatic
0.15
0.05
no dnr
24
67
19
95
28
36.69531
228.5625
null
null
1.599854
142
7.399414
83
30
null
null
7
<2 mo. follow-up
7
24
1
55.16199
female
0
10
Lung Cancer
Cancer
1
null
null
0
8,135
5,829.5977
5,938
1.5
white
19
11
0.690918
0.399963
1
0
0
metastatic
0.7
0.4
no dnr
10
57
15.398438
145
38
35.79688
230
null
0.599976
1.399902
142
7.389648
92
44
985
null
null
null
2.23584
66
1
40.271
male
0
21
CHF
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
58,691
31,759.5156
24,767
29.333328
white
20.199219
13
0.915894
0.85791
1
0
0
no
null
null
dnr after sadm
8
47
17.5
75
32
38.69531
134
1.899902
0.699951
1.099854
132
7.439453
107
18
1,659
0
1
no(M2 and SIP pres)
1
109
1
68.25494
male
0
12
ARF/MOSF w/Sepsis
ARF/MOSF
4
10
null
0
92,206
50,704.9062
57,568
36
white
25.199219
45
0.714966
0.62793
10
1
0
no
0.8
0.7
no dnr
12
62
9.699219
105
10
38
245.6875
null
null
1.5
134
7.489258
114
38
5,780
0
0
no(M2 and SIP pres)
0
752
0
84.29797
female
1
17
MOSF w/Malig
ARF/MOSF
0
16
$25-$50k
100
109,768
63,122.5938
61,147
46
white
40.898438
68
0.001
0
2
0
0
yes
null
null
dnr after sadm
17
132
8.599609
120
30
38.5
135
2.599609
null
0.899902
150
7.429688
153
17
3,570
null
3
<2 mo. follow-up
3
17
1
80.474
female
0
47
ARF/MOSF w/Sepsis
ARF/MOSF
0
18
>$50k
26
204,836
121,360.25
126,090
33.25
white
28.597656
49
0.417969
0.297974
27
0
0
no
null
null
no dnr
47
128
5
52
20
36.69531
null
3.899902
0.699951
1.299805
137
null
81
9
3,200
null
0
adl>=4 (>=5 if sur)
0
751
0
46.89099
male
1
7
ARF/MOSF w/Sepsis
ARF/MOSF
4
5
under $11k
44
50,893
30,054.4062
29,646
38
white
41.296875
88
0.267944
0.16098
3
0
0
no
0.1
0.1
dnr before sadm
-1
108
11.699219
115
24
38
297.3125
3.099609
0.599976
0.899902
133
7.469727
133
19
2,045
null
0
<2 mo. follow-up
0
7
1
67.90997
male
1
3
ARF/MOSF w/Sepsis
ARF/MOSF
0
null
null
0
49,488
29,109.1094
32,586
31
white
66.296875
111
0
0
12
0
0
no
null
null
dnr after sadm
1
66
10.5
70
12
36.29688
200
3.199707
0.599976
0.5
131
7.389648
98
15
3,680
null
null
<2 mo. follow-up
1.515381
3
1
89.07599
female
1
5
ARF/MOSF w/Sepsis
ARF/MOSF
1
11
null
0
63,254
37,061.9688
34,964
35
white
21.597656
55
0.680908
0.586914
14
0
0
no
0.5
0.3
dnr after sadm
1
77
23.398438
70
27
35.19531
266.625
null
0.299988
3.599609
146
7.399414
163
60
4,500
null
1
<2 mo. follow-up
1
5
1
40.20798
male
1
4
MOSF w/Malig
ARF/MOSF
2
14
null
100
84,543
52,347.1875
54,819
49
black
62.09375
118
0
0
22
0
0
yes
0.15
0.1
no dnr
4
73
4
65
20
38.09375
328.5625
2.799805
0.799927
1.399902
139
7.449219
107
13
null
null
null
<2 mo. follow-up
2.652832
4
1
47.64697
female
0
9
CHF
COPD/CHF/Cirrhosis
4
8
under $11k
0
42,225
23,947.1406
25,219
21.5
black
26.898438
51
0.796997
0.67395
7
1
0
no
0.7
0.6
no dnr
9
67
19.597656
140
34
38.09375
160
2.599609
0.399963
0.699951
143
7.449219
83
35
1,390
0
0
no(M2 and SIP pres)
0
400
1
59.461
female
0
13
Colon Cancer
Cancer
1
10
$25-$50k
0
19,294
11,926.1016
11,618
13
white
14.798828
16
0.852905
0.67395
1
0
0
metastatic
0.8
0.75
no dnr
13
52
11.298828
175
26
38.89844
53
null
1
1
131
7.279297
170
19
460
0
1
no(M2 and SIP pres)
1
747
0
64.44598
female
0
10
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
null
0
null
null
null
19
black
26.398438
51
0.773926
0.700928
1
1
0
no
null
null
dnr after sadm
5
118
52.09375
115
14
36.09375
104.20312
3.099609
24.597656
3.799805
138
7.479492
186
57
840
null
6
adl>=4 (>=5 if sur)
6
71
1
77.21295
male
0
38
MOSF w/Malig
ARF/MOSF
2
17
$25-$50k
44
null
103,211.875
96,555
31
white
28.597656
56
0.221985
0.123993
25
0
0
yes
0.8
0.8
no dnr
38
40
6.599609
0
8
37.89844
102
null
null
2.699707
144
7.389648
153
46
2,010
null
0
no(M2 and SIP pres)
0
748
0
47.79999
male
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
5
$11-$25k
9
51,266
30,347.0781
31,147
29.666656
white
36.5
61
0.593994
0.485962
2
1
0
no
null
null
no dnr
16
67
22.5
115
7
35.39844
165
3.199707
0.5
1.099854
139
7.399414
158
26
2,220
null
null
no(M2 and SIP pres)
2.268066
747
0
80.51996
female
1
17
ARF/MOSF w/Sepsis
ARF/MOSF
2
12
null
9
92,304
53,414
50,942
35.666657
white
22.199219
31
0.531982
0.416992
14
0
0
metastatic
0.6
0.2
dnr after sadm
15
42
19.097656
75
38
39
126.65625
null
1.799805
3.199707
139
7.459961
155
71
375
null
0
<2 mo. follow-up
0
17
1
57.125
male
0
8
Lung Cancer
Cancer
2
14
$25-$50k
0
19,218
10,343.4609
8,155
11
white
25.5
16
0.529907
0.20697
1
0
0
metastatic
0.8
0.5
no dnr
8
120
7.699219
115
32
38.29688
216.65625
null
1.099854
0.599976
142
7.399414
144
16
1,360
2
2
adl>=4 (>=5 if sur)
2
63
1
41.39398
male
0
7
Colon Cancer
Cancer
1
13
$11-$25k
0
16,309
9,141.0547
9,664
11.5
white
21.5
12
0.79895
0.572998
1
0
0
metastatic
null
null
dnr after sadm
1
125
8.099609
75
20
36.79688
null
null
null
1.299805
137
null
182
20
1,400
1
0
<2 mo. follow-up
0
33
1
60.95798
female
1
14
MOSF w/Malig
ARF/MOSF
1
10
under $11k
0
46,783
26,275.0781
29,210
31
black
24.699219
39
0.652954
0.553955
3
0
0
yes
0
0
dnr after sadm
7
103
7.699219
106
20
36.39844
null
null
0.5
1.5
136
null
141
20
null
null
2
<2 mo. follow-up
2
14
1
71.27197
male
0
3
Colon Cancer
Cancer
2
12
null
0
7,277
4,163.2031
4,064
8
white
15.199219
13
0.828979
0.62793
1
1
0
metastatic
null
null
no dnr
3
97
8.5
86
20
36.89844
null
4.299805
0.599976
0.899902
142
null
133
14
null
0
null
null
0.494751
357
1
42.27499
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
null
0
81,268
48,695.8438
50,227
22.666656
black
31.597656
77
0.710938
0.623901
10
0
0
no
0.95
0.95
no dnr
16
101
11.199219
110
42
35.5
214.8125
3
0.5
1
144
7.299805
87
31
1,700
0
0
SIP>=30
0
745
0
49.37698
female
0
37
ARF/MOSF w/Sepsis
ARF/MOSF
0
17
$25-$50k
94
null
57,057.7812
63,000
35.5
white
19.296875
37
0.659912
0.56189
1
0
0
no
0.15
0.1
dnr after sadm
15
115
20.398438
71
16
36.29688
null
2.199707
4.399414
0.699951
134
null
97
18
530
null
0
null
0
745
0
63.85199
female
0
6
Lung Cancer
Cancer
2
7
under $11k
0
7,383
4,555.8555
5,467
9
white
24.296875
23
0.53894
0.21698
1
0
0
metastatic
0.05
0
dnr after sadm
2
68
12.699219
135
6
38.19531
188.3125
null
null
1.799805
131
7.459961
154
41
3,860
null
6
<2 mo. follow-up
6
25
1
73.71399
male
0
36
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
$11-$25k
41
null
46,177.1562
46,321
30.5
white
35.898438
63
0.299988
0.188995
1
0
0
no
0.1
0.1
no dnr
36
110
4.599609
66
24
38.59375
null
null
1.099854
1.299805
141
null
265
9
null
null
0
null
0
72
1
62.379
female
1
111
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
>$50k
26
363,297
null
null
40.25
white
46.296875
71
0.163971
0.081985
1
1
0
no
0.8
0.7
no dnr
111
95
5.099609
78
20
36.59375
null
3.599609
0.599976
1.099854
140
null
104
8
5,625
null
0
adl>=4 (>=5 if sur)
0
111
1
65.01294
female
1
11
Coma
Coma
1
12
null
44
69,652
39,999.1562
36,347
36.5
black
27.5
60
0.291992
0.221985
9
0
0
no
0.5
0.25
dnr after sadm
11
142
6
105
10
35.39844
186.65625
1.899902
3.799805
1.799805
137
7.479492
165
40
4,653
null
0
<2 mo. follow-up
0
11
1
71.49097
female
0
46
ARF/MOSF w/Sepsis
ARF/MOSF
3
5
under $11k
100
71,954
46,952.9062
45,922
27.25
white
30.5
47
0.178986
0.091995
1
1
0
no
0.5
0.3
dnr after sadm
22
125
18.5
105
13
37.89844
165
1.799805
1.699951
4.799805
146
7.339844
75
59
1,660
null
2
<2 mo. follow-up
2
52
1
55.61398
male
0
6
Colon Cancer
Cancer
2
12
$25-$50k
0
7,829
null
null
13
white
34.195313
19
0.478943
0.161987
1
0
0
metastatic
0.8
0.5
no dnr
6
73
10.599609
65
24
39.19531
144
null
1.199951
1.299805
135
7.489258
216
28
3,130
3
null
<2 mo. follow-up
2.510742
49
1
77.04297
male
0
14
ARF/MOSF w/Sepsis
ARF/MOSF
1
10
$25-$50k
0
38,469
22,497.7969
24,782
19.666656
white
31.5
48
0.609985
0.50293
1
0
0
no
0.5
0.47
no dnr
14
65
11
135
45
38
182.84375
null
1.5
1.199951
143
7.40918
97
16
3,390
null
0
no(M2 and SIP pres)
0
742
0
85.03998
female
1
14
Coma
Coma
1
null
null
44
9,931
null
null
7.333332
black
16.898438
28
0.41095
0.336975
1
0
0
yes
0.1
0.01
dnr after sadm
2
113
7.799805
65
10
38
276.625
null
null
0.699951
129
7.509766
96
15
1,180
null
7
<2 mo. follow-up
7
14
1
60.54498
female
1
8
COPD
COPD/CHF/Cirrhosis
1
5
under $11k
44
40,885
22,991.3438
23,333
35.5
white
25.199219
25
0.654907
0.477966
4
0
0
no
0.8
0.7
dnr after sadm
8
89
5.699219
60
20
36.5
null
null
0.5
1
140
null
142
16
2,975
null
0
<2 mo. follow-up
0
8
1
65.03796
female
1
11
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
44
67,810
38,456.7188
35,168
46
black
35.796875
70
0.32196
0.207977
2
0
1
no
0.15
0.1
dnr after sadm
9
68
14.699219
80
10
35.59375
342.5
null
0.599976
5.599609
130
7.40918
129
129
560
null
1
<2 mo. follow-up
1
11
1
63.83298
female
1
8
Coma
Coma
0
null
null
44
27,301
15,918.8828
13,193
33.5
white
17.398438
18
0.670898
0.613892
1
0
0
no
0.1
0.1
dnr after sadm
4
68
29.597656
75
20
36.39844
null
2.899902
0.5
1.399902
134
null
115
30
null
null
null
<2 mo. follow-up
1.709473
8
1
51.87399
male
0
11
Cirrhosis
COPD/CHF/Cirrhosis
2
null
null
0
18,135
11,270.7422
11,102
9
white
14.599609
18
0.887939
0.812988
1
0
0
no
null
null
no dnr
11
62
2.099609
72
16
38
536
2.699707
0.5
0.5
138
7.439453
89
8
4,440
null
null
null
2.592773
728
0
18.88799
male
0
23
Coma
Coma
0
11
$25-$50k
55
61,596
37,417.375
37,582
21.333328
white
22.5
28
0.819946
0.784912
1
0
0
no
0.5
0.6
no dnr
23
112
18.296875
125
44
38.89844
120
2.699707
0.399963
2.099609
145
7.189453
417
45
1,445
null
0
no(M2 and SIP pres)
0
728
0
65.5
female
1
6
MOSF w/Malig
ARF/MOSF
2
12
under $11k
26
null
46,616.8125
45,603
47
white
37
75
0.121994
0.053993
18
1
0
yes
0.1
0.05
dnr after sadm
6
63
13.5
55
10
36.09375
310
null
2.399902
1
135
7.439453
93
20
2,135
null
1
<2 mo. follow-up
1
6
1
74.08099
female
0
10
COPD
COPD/CHF/Cirrhosis
2
7
under $11k
0
10,223
6,574.7031
7,437
9.5
white
15.398438
18
0.871948
0.786987
1
0
0
no
0.7
0.6
no dnr
10
62
6.899414
115
36
39.59375
157.5
null
null
0.899902
134
7.489258
424
16
2,145
1
2
no(M2 and SIP pres)
2
589
1
62.14398
male
0
10
Lung Cancer
Cancer
1
8
$11-$25k
0
12,666
7,809.8164
8,016
16.5
white
17
12
0.713989
0.434998
1
0
0
metastatic
0.8
0.4
no dnr
10
104
10.898438
70
20
36.39844
316
4
0.599976
0.699951
137
7.399414
147
22
2,200
0
0
adl>=4 (>=5 if sur)
0
77
1
73.56897
male
1
15
CHF
COPD/CHF/Cirrhosis
4
12
under $11k
0
69,294
36,262
40,435
50.333313
white
25.199219
45
0.759888
0.619995
1
1
0
no
0.6
0.5
dnr after sadm
13
65
2.899902
135
30
39.19531
228.5625
null
0.699951
1.199951
147
7.369141
231
31
3,775
null
2
<2 mo. follow-up
2
15
1
65.08398
female
0
49
Coma
Coma
1
11
under $11k
9
244,277
142,366.5
146,695
44.5
black
29.097656
49
0.304993
0.234985
26
0
0
yes
0.3
0.3
dnr after sadm
43
77
12.298828
100
20
36.69531
null
3.099609
0.399963
1
142
null
92
16
null
null
1
adl>=4 (>=5 if sur)
1
64
1
81.96594
female
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
0
9
under $11k
0
55,711
34,053.3125
38,240
29
white
27.699219
35
0.646973
0.546997
2
0
0
no
0.75
0.6
no dnr
22
86
10.798828
75
24
36.09375
195.21875
null
null
0.599976
139
7.289062
126
8
null
null
1
null
1
725
0
55.55899
female
0
6
CHF
COPD/CHF/Cirrhosis
5
16
>$50k
0
4,390
3,090.0312
3,410
9
white
18.398438
40
0.898926
0.830933
1
1
0
no
null
null
no dnr
6
43
11.599609
140
25
38.19531
119.98438
1.699951
6.399414
2.799805
145
7.389648
117
60
1,460
1
null
no(M2 and SIP pres)
1.166748
726
0
72.43799
male
0
10
Colon Cancer
Cancer
1
16
null
0
29,470
16,680.2812
16,380
31.5
white
45.398438
39
0.109985
0.004
1
0
0
metastatic
0.85
0.75
no dnr
10
78
36.09375
75
8
36.19531
286.625
2.5
0.599976
1.899902
149
7.439453
293
54
2,265
0
null
no(M2 and SIP pres)
0.494751
726
0
71.62195
female
0
31
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
null
null
null
13
white
17.398438
31
0.861938
0.771973
1
0
0
no
0.9
0.9
dnr after sadm
5
125
18
45
12
36
356
null
0.5
2.699707
138
7.369141
80
36
2,965
4
2
adl>=4 (>=5 if sur)
2
74
1
62.25299
male
0
9
COPD
COPD/CHF/Cirrhosis
3
5
$11-$25k
0
8,922
5,818.3086
6,201
10.5
white
16.097656
13
0.908936
0.845947
1
0
0
no
0.6
0.5
no dnr
9
57
0.299988
115
24
35
226.65625
null
null
0.899902
133
7.5
385
23
1,000
0
null
no(M2 and SIP pres)
0.494751
725
0
73.47595
female
0
23
MOSF w/Malig
ARF/MOSF
2
null
null
0
173,420
106,988
115,884
42
white
41
60
0.119995
0.052994
22
1
0
yes
0.1
0.1
no dnr
23
97
23.398438
125
26
38.29688
120.40625
null
null
1.299805
134
7.319336
181
5
2,065
null
0
no(M2 and SIP pres)
0
173
1
21.092
male
0
17
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
$11-$25k
0
85,249
null
null
33
white
21.5
23
0.927979
0.901978
1
0
0
no
null
null
no dnr
17
0
12.298828
0
40
34.89844
45
2.5
0.699951
1.199951
136
7.319336
134
67
1,130
null
null
no(M2 and SIP pres)
1.738525
724
0
73.96295
female
0
20
MOSF w/Malig
ARF/MOSF
1
12
under $11k
9
52,654
32,165.2656
29,805
24.333328
black
14.298828
42
0.737915
0.655884
5
0
0
metastatic
0.1
0.5
dnr after sadm
2
138
24.199219
155
36
36.5
152.5
1.099854
1.5
2.299805
131
7.489258
123
30
638
null
3
SIP>=30
3
360
1
85.04297
male
0
22
ARF/MOSF w/Sepsis
ARF/MOSF
0
16
$11-$25k
0
45,706
27,916.375
28,557
19.333328
white
24.5
37
0.677979
0.583984
4
0
0
no
0.4
0.4
no dnr
22
75
10.5
54
16
36.59375
null
3.299805
0.399963
0.899902
139
null
74
15
null
null
4
SIP>=30
4
517
1
35.32397
female
0
25
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
44
109,937
64,685.5938
64,654
29
white
34.09375
55
0.501953
0.383972
11
0
0
no
0.6
0.6
no dnr
25
102
9.199219
125
22
36.39844
236.65625
null
null
1.099854
135
7.449219
89
13
3,725
null
null
null
2.575195
723
0
67.75397
female
0
6
CHF
COPD/CHF/Cirrhosis
3
8
under $11k
0
5,817
4,031.8711
4,050
17
black
22.796875
27
0.819946
0.706909
1
0
0
no
null
null
no dnr
6
53
12.5
105
36
38.5
223.3125
null
null
1.399902
138
7.459961
269
28
2,275
3
3
<2 mo. follow-up
3
42
1
61.728
male
1
11
Coma
Coma
0
null
null
61
40,375
22,013.4062
23,827
31.5
white
24
36
0.41095
0.336975
2
0
0
no
0
0
dnr after sadm
8
58
3
35
30
34.89844
395.1875
2.599609
1.299805
2.099609
126
7.539062
705
46
3,820
null
null
<2 mo. follow-up
2.580566
11
1
60.435
male
0
18
ARF/MOSF w/Sepsis
ARF/MOSF
1
6
under $11k
41
31,813
19,738.3906
22,031
19.333328
white
18.898438
16
0.766968
0.691895
3
0
0
no
0.8
0.75
no dnr
18
110
10.298828
120
40
38.69531
152.5
null
null
0.5
139
7.489258
189
25
2,805
null
1
adl>=4 (>=5 if sur)
1
721
0
63.72098
male
0
19
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
9
56,207
33,346.6562
32,873
17.666656
white
35
44
0.482971
0.36499
6
0
0
no
0.4
0.3
no dnr
19
60
11.798828
120
30
35.59375
172.5
null
21.796875
8.898438
139
7.369141
168
83
9
0
5
no(M2 and SIP pres)
5
193
1
72.79095
female
0
13
CHF
COPD/CHF/Cirrhosis
3
7
$11-$25k
0
null
19,391.375
20,858
18
white
21.699219
26
0.815918
0.701904
1
1
0
no
null
null
no dnr
13
22
29.699219
0
0
37.59375
478
null
null
3.599609
126
7.229492
536
39
64
0
0
no(M2 and SIP pres)
0
721
0
25.95499
female
0
13
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
>$50k
0
null
null
null
15
white
20.597656
24
0.910889
0.878906
5
0
0
no
0.9
0.9
no dnr
13
58
9.298828
80
35
38.09375
243.3125
null
null
2.699707
143
7.5
108
111
1,785
0
0
no(M2 and SIP pres)
0
720
0
46.146
female
0
31
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
55
116,527
66,050.1875
67,149
39.5
white
30.199219
38
0.539917
0.425964
3
0
0
no
0.5
0.4
no dnr
31
52
1.099854
135
38
38.59375
44
null
22
4.5
150
7.129883
87
143
15
null
0
no(M2 and SIP pres)
0
720
0
65.37396
male
0
13
CHF
COPD/CHF/Cirrhosis
4
null
null
9
null
15,356.0469
13,818
23.5
white
20
28
0.843994
0.74292
1
1
0
no
null
null
no dnr
13
158
12.5
105
12
38.29688
356
2.899902
null
7.599609
138
7.349609
312
61
450
null
null
<2 mo. follow-up
3.125488
57
1
54.08899
male
0
7
Lung Cancer
Cancer
1
12
under $11k
0
null
7,479.207
7,614
12.5
black
22.398438
25
0.616943
0.302979
1
0
0
metastatic
null
null
no dnr
7
72
5.899414
75
16
36.5
null
null
0.399963
0.699951
143
null
77
13
1,475
null
0
no(M2 and SIP pres)
0
718
0
20.31799
female
0
16
ARF/MOSF w/Sepsis
ARF/MOSF
1
13
$11-$25k
0
70,709
39,993.9062
35,131
32.333313
white
27.398438
32
0.858887
0.810913
1
0
0
yes
0.5
0.5
no dnr
16
115
11.298828
75
27
33.89844
263.3125
null
0.699951
1.599854
148
7.399414
327
42
1,255
null
0
no(M2 and SIP pres)
0
719
0
60.82098
male
0
10
Coma
Coma
3
7
under $11k
0
null
25,320.9062
30,608
31.5
black
22
22
0.675903
0.619995
2
0
0
yes
0.8
0.75
no dnr
10
62
7.599609
145
10
39.09375
175
2.5
4
2
147
7.509766
149
77
1,520
null
0
no(M2 and SIP pres)
0
718
0